Columnmate Beta Thal HBA2 Control-Abnormal
FDA 510(k) K923317 · Helena Laboratories
510(k) numberK923317
Submission
- Device name
- Columnmate Beta Thal HBA2 Control-Abnormal
- Applicant
- Helena Laboratories
Beaumont, TX, US - Received
- July 7, 1992
- Decision date
- August 25, 1992
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) statement available from FDA
Device classification
- Product code
- JPD – Hemoglobin A2 Quantitation
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 864.7400
- Specialty
- Hematology
Other 510(k)s with product code JPD
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K020489 | G7 Automated HPLC Analyzer, Beta-Thalassemia ModeJPD · Traditional | Tosoh Medics, Inc. | 05/14/2002SE |
| K991127 | Variant II B-ThalassemiaJPD · Special | Bio-Rad | 06/10/1999SE |
| K924122 | Variant Beta-Thalassemia Short ProgramJPD · Traditional | Bio-Rad | 03/11/1993SE |
| K924496 | Glycomat Green HBA2 Estimation Reagent KitJPD · Traditional | Drew Scientific , Ltd. | 11/16/1992SE |
| K923318 | Columnmate Beta-Thal HBA2 Control - NormalJPD · Traditional | Helena Laboratories | 08/25/1992SE |
| K913384 | Columnmate(Tm) Beta-Thal Cat. No. 4515JPD · Traditional | Helena Laboratories | 12/17/1991SE |
| K896168 | Hemoglobin A2 Micro Column TestJPD · Traditional | Bio-Rad | 01/18/1990SE |
| K875102 | Deter. of Hemoglobin A2 Using the DiamatJPD · Traditional | Bio-Rad | 02/24/1988SE |
| K823870 | Beta Thalquik Column #5341JPD · Traditional | Helena Laboratories | 02/01/1983SE |
| K812077 | Helena Sickle-Thal Quik Column MethodJPD · Traditional | Helena Laboratories | 08/18/1981SE |
More from Helena Laboratories
| 510(k) | Device | Decision |
|---|---|---|
| K213396 | SPIFE A1AT kitOBZ · Traditional | 10/13/2022SE |
| K192931 | V8 Nexus Hemoglobin Ultrascreen, V8 AFSA2 Hemo ControlGKA · Traditional | 04/19/2022SE |
| K131479 | V8 SP Normal Control, Abnormal ControlJJY · Traditional | 10/07/2013SE |
| K100103 | Specialty Assayed CONTROL-2GGC · Traditional | 12/15/2010SE |
| K061991 | Plateletworks Arachidonic Acid, Model Pw-AcaGHR · Traditional | 02/23/2007SE |
| K061069 | Spife IFE-15 Pentavalent, Model 3456, Spife IFE-9 Pentavalent Kit, Model 3457, Spift…CFF · Traditional | 07/06/2006SE |
| K061014 | Actalyke QC Kit, Models Aqc-Hp and Aqc-LpJPA · Special | 05/10/2006SE |
| K050053 | Hemoram/Aggram AnalyzerJPA · Traditional | 07/11/2005SE |
| K024162 | Spife 3000 Titan Gel Igg Ief Kit, Model 3389CFF · Traditional | 02/19/2003SE |
| K023761 | Plateletworks, Models Pw-A, Pw-CJOZ · Traditional | 02/14/2003SE |
Questions and answers
When was Columnmate Beta Thal HBA2 Control-Abnormal cleared by the FDA?
Columnmate Beta Thal HBA2 Control-Abnormal (K923317) received a 510(k) decision of Substantially Equivalent on August 25, 1992, 49 days after the submission was received.
What is the product code of K923317?
The FDA product code is JPD – Hemoglobin A2 Quantitation, a Class II (moderate risk) device regulated under 21 CFR 864.7400.